U.S., Jan. 21 -- An application to own the trademark for 'BAYLINZ' has been filed on Aug. 06, 2025.
Owner(s):
Amylyx Pharmaceuticals, Inc.; 43 Thorndike Street, Suite S1-2B, , MASSACHUSETTS
Goods and/or Services:
For: Pharmaceutical preparations for the treatment of endocrine, metabolic, and hormonal related diseases and disorders
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2026-01-20&serialNumber=99323845
Disclaimer: Curated by HT Syndication....